Quick answer: AOD-9604 produced promising results in some animal studies, but the largest human trial did not show a meaningful weight-loss benefit over placebo. That trial tested a daily tablet, not the injectable form often discussed online. The human safety data are more reassuring than the efficacy data, but they...

The landscape of peptide research is shifting. On July 23–24, 2026, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) will convene at the White Oak campus to discuss the future of several high-profile research compounds. On the agenda are some of the most discussed peptides in the modern research community: BPC-157,...

If you’ve spent more than five minutes browsing the world of research peptides, you’ve seen the badge. It’s usually gold or green, slapped onto a product page, and reads: "Third-Party Tested." In an industry that moves as fast as biotechnology, that label is supposed to be your safety net. But...